Abstract:Naringenin (4,5,7-trihydroxyflavone, NAR) is an effective active ingredient in Rhizoma Drynariae, which has many biological functions, encompassing anti-inflammatory and -oxidant functions. Prior research has shown that NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasomes possessed a significant contribution to osteoporosis. However, the NAR impact on bone loss caused by microgravity remains unclear. Classical microgravity simulation methods were used to induce simulated microgravity (SMG) in mice and cells. Microcomputed tomography, immunohistochemical examination, and hematoxylin and eosin staining were implemented to ascertain alterations in bone microstructure and morphology in mice subsequent to NAR gavage. Cellular investigations were implemented encompassing quantitative real-time polymerase chain reaction, Western blotting, and immunofluorescence labeling to investigate the molecular mechanism behind NAR resistance to microgravity-induced bone loss. Our research has shown that NAR can significantly enhance the SMG-stimulated alterations in bone microstructure and morphology in mice, mainly by increasing the trabecular thickness, bone volume fraction, and trabecular number while increasing the bone trabecula number. Cell experiments also showed that SMG caused the activation of inflammatory corpuscles of NLRP3 and induced pyroptosis simultaneously, which can be confirmed by the upregulation of protein and mRNA expression levels such as those of NLRP3, cleaved caspase-1, gasdermin D, and apoptosis-associated speck-like protein. The occurrence of pyroptosis further led to the disorder of osteogenic differentiation, which showed that the osteopontin, Runt-related transcription factor 2, bone morphogenetic protein 2, and alkaline phosphatase expression levels were decreased. The intervention of NAR can activate the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) pathway, reverse this phenomenon via controlling the reactive oxygen species generation in cells and correcting mitochondrial malfunction, weaken the pyroptosis of osteoblasts (OBs), and promote osteogenic differentiation. In summary, NAR could hinder the pyroptosis of OBs caused by SMG and promote osteogenic differentiation via activating the Nrf2/HO-1 pathway. This provides a unique view for inhibiting bone loss under weightlessness and confirms the NAR capacity in treating microgravity-stimulated bone loss, giving new ideas and methods for future space medicine development.

Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression

Recombinant Irisin Prevents The Reduction Of Osteoblast Differentiation Induced By Stimulated Microgravity Through Increasing Beta-Catenin Expression

Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission

Irisin Enhances Osteogenic Differentiation of Mouse MC3T3-E1 Cells Via Upregulating Osteogenic Genes

Mir-138–5P Negatively Regulates Osteoblast Differentiation Through Inhibiting Β-Catenin under Simulated Microgravity in MC3T3-E1 Cells

Irisin Prevents Disuse‐Induced Osteocyte Apoptosis

Myokine Irisin promotes osteogenesis by activating BMP/SMAD signaling via αV integrin and regulates bone mass in mice

Irisin Deficiency Disturbs Bone Metabolism

Osthole ameliorates simulated microgravity-induced bone loss through down-regulation of miR-34c-5p

Irisin Promotes Osteoblast Proliferation and Differentiation Via Activating the MAP Kinase Signaling Pathways

Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells.

Effect of recombinant irisin on recombinant human bone morphogenetic protein-2 induced osteogenesis and osteoblast differentiation

Irisin As an Agent for Protecting Against Osteoporosis: A Review of the Current Mechanisms and Pathways.

Irisin Promotes Fracture Healing by Improving Osteogenesis and Angiogenesis

Inhibition of SIRT1 by Mir-138-5p Provides a Mechanism for Inhibiting Osteoblast Proliferation and Promoting Apoptosis under Simulated Microgravity

Preventing Disused Bone Loss Through Inhibition of Advanced Glycation End Products.

Irisin Protects Musculoskeletal Homeostasis via a Mitochondrial Quality Control Mechanism

Irisin Promotes Osteogenesis by Modulating Oxidative Stress and Mitophagy through SIRT3 Signaling under Diabetic Conditions

Naringenin can Inhibit the Pyroptosis of Osteoblasts by Activating the Nrf2/HO-1 Signaling Pathway and Alleviate the Differentiation Disorder of Osteoblasts Caused by Microgravity

Irisin Inhibits Osteocyte Apoptosis By Activating The Erk Signaling Pathway In Vitro And Attenuates Alct-Induced Osteoarthritis In Mice

Irisin improves delayed bone repair in diabetic female mice